Diligence memo · auto-generated · as of July 2, 2026

Scientia Vascular, Inc.

Scientia Vascular, Inc. looks under-valued against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

Scientia Vascular, Inc. operates in Other Health Care, based in WEST VALLEY CITY.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Scientia Vascular, Inc. has raised $55M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $50M on 2021-05-26.

Most recent recorded round closed around 2023-11-15.

Valuation (modeled)modeled

Provath models Scientia Vascular, Inc. at approximately $48M (range $18M–$80M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.07× the median modeled value of Series C Other Health Care companies in 2022–2024 (47 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 30 months.

Last raise 2.6 yr ago; this sector typically re-raises about every 14 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round was 10.0× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 93% of Other Health Care peers (5377 compared).

Modeled value ranks above 66% of those peers.

Closest niche peers: Gravie, Inc., EmpowerMe Holdings, LLC, Color Holdings, L.P., RSR Senior Residences, LLC, Gynesonics, Inc.

Peoplefiled

13 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.